These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 30047279

  • 1. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel GF.
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
    [Abstract] [Full Text] [Related]

  • 2. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, Salata R, Doncel GF.
    J Acquir Immune Defic Syndr; 2014 Jun 01; 66(2):109-17. PubMed ID: 24413042
    [Abstract] [Full Text] [Related]

  • 3. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.
    mBio; 2015 Sep 01; 6(5):e00221-15. PubMed ID: 26330510
    [Abstract] [Full Text] [Related]

  • 4. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
    Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.
    AIDS Res Hum Retroviruses; 2016 May 01; 32(5):443-51. PubMed ID: 26650885
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN, Morrison CS, Chen PL, Yamamoto HS, Govender Y, Junaid D, Ryan S, Kwok C, Chipato T, Salata RA, Doncel GF.
    PLoS One; 2020 May 01; 15(1):e0224359. PubMed ID: 31914129
    [Abstract] [Full Text] [Related]

  • 7. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA, Aldous A, Daniels J, Joy C, Capozzi E, Yang M, Moriarty P, Emmanuel-Baker V, Malcolm S, Green SJ, Gomez-Lobo V, Ghosh M.
    PLoS One; 2024 May 01; 19(7):e0306237. PubMed ID: 39008499
    [Abstract] [Full Text] [Related]

  • 8. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion.
    Govender Y, Morrison CS, Chen PL, Gao X, Yamamoto H, Chipato T, Anderson S, Barbieri R, Salata R, Doncel GF, Fichorova RN.
    Sex Transm Infect; 2023 Aug 01; 99(5):311-316. PubMed ID: 36104248
    [Abstract] [Full Text] [Related]

  • 9. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
    Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE.
    J Womens Health (Larchmt); 2017 Jun 01; 26(6):670-676. PubMed ID: 28437215
    [Abstract] [Full Text] [Related]

  • 10. Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.
    Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR.
    AIDS Res Hum Retroviruses; 2019 Mar 01; 35(3):236-246. PubMed ID: 30585733
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.
    Lancet Glob Health; 2015 Aug 01; 3(8):e478-e486. PubMed ID: 26094162
    [Abstract] [Full Text] [Related]

  • 13. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
    Thurman A, Chandra N, Schwartz JL, Brache V, Chen BA, Asin S, Rollenhagen C, Herold BC, Fichorova RN, Hillier SL, Weiner DH, Mauck C, Doncel GF.
    AIDS Res Hum Retroviruses; 2019 Sep 01; 35(9):853-864. PubMed ID: 30997816
    [Abstract] [Full Text] [Related]

  • 14. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, Patel S, Ahmed K, Ramjee G, Friedland B, Lahteenmaki P.
    AIDS; 2012 Feb 20; 26(4):497-504. PubMed ID: 22156973
    [Abstract] [Full Text] [Related]

  • 15. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
    Bengtson A, Kwok C, Salata RA, Byamugisha J, Chipato T, Rwambuya S, Moyo P, Morrison CS.
    J Acquir Immune Defic Syndr; 2013 Aug 01; 63(4):506-13. PubMed ID: 23572011
    [Abstract] [Full Text] [Related]

  • 16. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
    Morrison CS, Chen PL, Nankya I, Rinaldi A, Van Der Pol B, Ma YR, Chipato T, Mugerwa R, Dunbar M, Arts E, Salata RA.
    J Acquir Immune Defic Syndr; 2011 Jun 01; 57(2):157-64. PubMed ID: 21358412
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
    van de Wijgert JH, Verwijs MC, Turner AN, Morrison CS.
    AIDS; 2013 Aug 24; 27(13):2141-53. PubMed ID: 23660575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.